This week's View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including articles questioning how comorbidities and neighborhood characteristics impact race-related COVID-19 outcomes, Key Points to Remember from an expert consensus statement on screening of potential cardiac involvement in competitive athletes recovering from COVID-19, and the WHO Solidarity trial assessing the safety and efficacy of four drugs (remdesivir, hydroxychloroquine, lopinavir, interferon) among patients hospitalized with COVID-19.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Arrhythmias and Clinical EP, Cardiovascular Care Team, COVID-19 Hub, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Pericardial Disease, Prevention, Sports and Exercise Cardiology, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Novel Agents, Statins, Interventions and Imaging, Angiography, Echocardiography/Ultrasound, Magnetic Resonance Imaging, Nuclear Imaging, Exercise, Sports and Exercise and ECG and Stress Testing, Sports and Exercise and Imaging

Keywords: EaglesEyeView, ACC COVID-19 Podcast, COVID-19, Coronavirus, severe acute respiratory syndrome coronavirus 2, Critical Illness, African Americans, Healthcare Disparities, Hispanic Americans, Hospices, Patient Discharge, Primary Prevention, Respiration, Artificial, Socioeconomic Factors, Ventilation, Arrhythmias, Cardiac, Athletes, Coronary Angiography, Death, Sudden, Echocardiography, Electrocardiography, Exercise, Exercise Test, Magnetic Resonance Imaging, Myocarditis, Pericardial Effusion, Pericarditis, Physical Examination, Secondary Prevention, Troponin, Ventricular Dysfunction, Coronavirus Infections, Extracorporeal Membrane Oxygenation, Hospital Mortality, Hydroxychloroquine, Inpatients, Interferons, Lopinavir, remdesivir, Ritonavir

< Back to Listings